{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:43:46Z","timestamp":1790808226383,"version":"4.1.0"},"reference-count":189,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jaut.2021.102727","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T23:30:56Z","timestamp":1633044656000},"page":"102727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Insights into the knowledge of complex diseases: Environmental infectious\/toxic agents as potential etiopathogenetic factors of systemic sclerosis"],"prefix":"10.1016","volume":"124","author":[{"given":"Clodoveo","family":"Ferri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Cristina","family":"Arcangeletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Caselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystyna","family":"Zakrzewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Maccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Calderaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"D'Accolti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Soffritti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Arvia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Sighinolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Artoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilia","family":"Giuggioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2021.102727_bib1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2021.102727_bib2","series-title":"Kelley Firestein's Textb. Rheumatol","first-page":"1424","article-title":"Clinical features and treatment of scleroderma","author":"Wigley","year":"2017"},{"key":"10.1016\/j.jaut.2021.102727_bib3","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.autrev.2014.08.029","article-title":"Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature","volume":"13","author":"Ferri","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102727_bib4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.semarthrit.2019.09.019","article-title":"Challenges in systemic sclerosis trial design","volume":"49","author":"Denton","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102727_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.autrev.2008.07.022","article-title":"Systemic sclerosis and infections","volume":"8","author":"Randone","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102727_bib6","first-page":"627","article-title":"The role of infections in the immunopathogensis of systemic sclerosis-evidence from serological studies","author":"Arnson","year":"2009"},{"key":"10.1016\/j.jaut.2021.102727_bib7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.autrev.2010.09.010","article-title":"Do infections facilitate the emergence of systemic sclerosis?","volume":"10","author":"Grossman","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102727_bib8","article-title":"Role of viral infections in the etiopathogenesis of systemic sclerosis","volume":"31","author":"Moroncini","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102727_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10067-016-3533-1","article-title":"Occupational and environmental scleroderma. Systematic review and meta-analysis","volume":"36","author":"Rubio-Rivas","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102727_bib10","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.autrev.2018.07.003","article-title":"Autoinflammatory\/autoimmunity syndrome induced by adjuvants (ASIA; Shoenfeld's syndrome): a new flame","volume":"17","author":"Cohen Tervaert","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102727_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.autrev.2017.01.004","article-title":"Systemic sclerosis and exposure to heavy metals: a case control study of 100 patients and 300 controls","volume":"16","author":"Marie","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102727_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/ACI.0000000000000350","article-title":"Silicosis and autoimmunity","volume":"17","author":"Lee","year":"2017","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102727_bib13","first-page":"387","article-title":"Diffuse sclerodermia: its frequency; its occurrence in stone-masons; its treatment by fibrolysin\u2014elevations of temperature due to fibrolysin injections","volume":"12","author":"Bramwell","year":"1914","journal-title":"Edinb. Med. J."},{"key":"10.1016\/j.jaut.2021.102727_bib14","first-page":"209","article-title":"Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations","volume":"3","author":"Erasmus","year":"1957","journal-title":"S. Afr. J. Lab. Clin. Med."},{"key":"10.1016\/j.jaut.2021.102727_bib15","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/00002281-200211000-00011","article-title":"Role of infectious agents in the pathogenesis of systemic sclerosis","volume":"14","author":"Hamamdzic","year":"2002","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102727_bib16","first-page":"348","article-title":"Infectious disease as aetiological factor in the pathogenesis of systemic sclerosis","volume":"68","author":"Mislav","year":"2010","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.jaut.2021.102727_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00272","article-title":"Pathogenesis of systemic sclerosis","volume":"6","author":"Pattanaik","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2021.102727_bib18","first-page":"1306","article-title":"Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjogren's syndrome","volume":"26","author":"Aragona","year":"1999","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102727_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1046\/j.1523-5378.2002.00092.x","article-title":"Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60","volume":"7","author":"Kalabay","year":"2002","journal-title":"Helicobacter"},{"key":"10.1016\/j.jaut.2021.102727_bib20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3748\/wjg.v20.i3.613","article-title":"Helicobacter pylori and autoimmune disease: cause or bystander","volume":"20","author":"Smyk","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102727_bib21","first-page":"S168","article-title":"Helicobacter pylori infection in systemic sclerosis: a systematic review and meta-analysis of observational studies","volume":"36","author":"Yong","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102727_bib22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2249.2004.02535.x","article-title":"Mycoplasma infection induces a scleroderma-like centrosome autoantibody response in mice","volume":"137","author":"Gavanescu","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2021.102727_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MAJ.0b013e3181891612","article-title":"Lack of evidence for bacterial infections in skin in patients with systemic sclerosis","volume":"337","author":"Mayes","year":"2009","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.jaut.2021.102727_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/S1590-8658(07)80005-3","article-title":"HCV-related autoimmune and neoplastic disorders: the HCV syndrome","volume":"39","author":"Ferri","year":"2007","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.jaut.2021.102727_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12016-007-8013-6","article-title":"Hepatitis B virus (HBV) and autoimmune disease","volume":"34","author":"Maya","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2021.102727_bib26","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00296-009-1009-1","article-title":"Discoid lupus erythematosus in a patient with scleroderma and hepatitis C virus infection","volume":"30","author":"Yamamoto","year":"2010","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2021.102727_bib27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/BOR.0000000000000623","article-title":"The association between hepatitis B, hepatitis C and systemic sclerosis: a cross-sectional study","volume":"31","author":"Tiosano","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102727_bib28","article-title":"Screening of human papillomavirus infection in women with systemic sclerosis","volume":"32","author":"Martin","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102727_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13887","article-title":"Association of human papillomavirus and systemic sclerosis: a population based cohort study","volume":"75","author":"Chen","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.jaut.2021.102727_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/08830189509056710","article-title":"Retroviruses and the pathogenesis of systemic sclerosis","volume":"12","author":"Jimenez","year":"1995","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.jaut.2021.102727_bib31","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1651-2227.1979.tb18459.x","article-title":"Localized scleroderma following varicella in a three-year-old girl with IgA deficiency","volume":"68","author":"Spirer","year":"1979","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.jaut.2021.102727_bib32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00442996","article-title":"Unusual case of progressive systemic sclerosis with onset in early childhood and following infectious mononucleosis","volume":"136","author":"Urano","year":"1981","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.jaut.2021.102727_bib33","first-page":"681","article-title":"Localized scleroderma after infection with Epstein-Barr virus","volume":"11","author":"Longo","year":"1993","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102727_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1237-9","article-title":"Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes","volume":"19","author":"Farina","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2021.102727_bib35","first-page":"S3","article-title":"One year in review 2019: systemic sclerosis","volume":"37","author":"Barsotti","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102727_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.clim.2019.07.012","article-title":"A comprehensive analysis of antigen-specific antibody responses against human cytomegalovirus in patients with systemic sclerosis","volume":"207","author":"Efthymiou","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102727_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/v13020260","article-title":"Human cytomegalovirus and autoimmune diseases: where are we?","volume":"13","author":"Gugliesi","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jaut.2021.102727_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/472978","article-title":"Human cytomegalovirus and autoimmune disease","author":"Halenius","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jaut.2021.102727_bib39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/16066350500095415","article-title":"New developments in the pathogenesis of systemic sclerosis","volume":"38","author":"Sakkas","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2021.102727_bib40","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/art.20315","article-title":"Is systemic sclerosis an antigen-driven T cell disease?","volume":"50","author":"Sakkas","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102727_bib41","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","article-title":"The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review","volume":"16","author":"Mostmans","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102727_bib42","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1099\/0022-1317-76-4-741","article-title":"Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues","volume":"76","author":"Sinzger","year":"1995","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jaut.2021.102727_bib43","doi-asserted-by":"crossref","DOI":"10.1186\/ar4230","article-title":"Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells","volume":"15","author":"Gilbane","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2021.102727_bib44","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/80533","article-title":"Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells","volume":"6","author":"Lunardi","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2021.102727_bib45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00430-015-0396-z","article-title":"Human cytomegalovirus riding the cell cycle","volume":"204","author":"Spector","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.jaut.2021.102727_bib46","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/jcb.22268","article-title":"Modulatory effect of rRNA synthesis and ppUL83 nucleolar compartmentalization on human cytomegalovirus gene expression in vitro","volume":"108","author":"Arcangeletti","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jaut.2021.102727_bib47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/jcb.22928","article-title":"Cell-cycle-dependent localization of human cytomegalovirus UL83 phosphoprotein in the nucleolus and modulation of viral gene expression in human embryo fibroblasts in vitro","volume":"112","author":"Arcangeletti","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jaut.2021.102727_bib48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virol.2013.01.021","article-title":"Toll-like receptor 4 is involved in the cell cycle modulation and required for effective human cytomegalovirus infection in THP-1 macrophages","volume":"440","author":"Arcangeletti","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.jaut.2021.102727_bib49","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/ard.61.10.937","article-title":"Systemic sclerosis following human cytomegalovirus infection","volume":"61","author":"Ferri","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102727_bib50","first-page":"94","article-title":"Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach","volume":"3","author":"Lunardi","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.jaut.2021.102727_bib51","first-page":"S31","article-title":"Increased immunoreactivity against human cytomegalovirus UL83 in systemic sclerosis","volume":"35","author":"Marou","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102727_bib52","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/08916930410001710046","article-title":"IgG antibodies to human cytomegalovirus late protein UL94 in patients with systematic sclerosis","volume":"37","author":"Namboodiri","year":"2004","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2021.102727_bib53","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00296-020-04643-z","article-title":"A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies","volume":"40","author":"Gkoutzourelas","year":"2020","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2021.102727_bib54","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/1529-0131(199902)42:2<389::AID-ANR23>3.0.CO;2-P","article-title":"Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis","volume":"42","author":"Michel","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102727_bib55","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.4049\/jimmunol.168.7.3649","article-title":"Oligoclonal T cell expansion in the skin of patients with systemic sclerosis","volume":"168","author":"Sakkas","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102727_bib56","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11357-017-9986-6","article-title":"CMV immune evasion and manipulation of the immune system with aging","volume":"39","author":"Jackson","year":"2017","journal-title":"GeroScience"},{"key":"10.1016\/j.jaut.2021.102727_bib57","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11357-017-9982-x","article-title":"A constant companion: immune recognition and response to cytomegalovirus with aging and implications for immune fitness","volume":"39","author":"Souquette","year":"2017","journal-title":"GeroScience"},{"key":"10.1016\/j.jaut.2021.102727_bib58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.imlet.2017.10.002","article-title":"Current perspectives on the role of CD8+ T cells in systemic sclerosis","volume":"195","author":"Fuschiotti","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jaut.2021.102727_bib59","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.4049\/jimmunol.179.6.4283","article-title":"Massive load of functional effector CD4 + and CD8 + T cells against cytomegalovirus in very old subjects","volume":"179","author":"Vescovini","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102727_bib60","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11357-013-9594-z","article-title":"Na\u00efve and memory CD8 T cell pool homeostasis in advanced aging: impact of age and of antigen-specific responses to cytomegalovirus","volume":"36","author":"Vescovini","year":"2014","journal-title":"Age (Omaha)."},{"key":"10.1016\/j.jaut.2021.102727_bib61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12026-011-8251-9","article-title":"Buffered memory: a hypothesis for the maintenance of functional, virus-specific CD8 + T cells during cytomegalovirus infection","volume":"51","author":"Snyder","year":"2011","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jaut.2021.102727_bib62","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00430-012-0273-y","article-title":"Viral latency drives \u201cmemory inflation\u201d: a unifying hypothesis linking two hallmarks of cytomegalovirus infection","volume":"201","author":"Seckert","year":"2012","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.jaut.2021.102727_bib63","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.exger.2014.03.020","article-title":"New advances in CMV and immunosenescence","volume":"55","author":"Sansoni","year":"2014","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.jaut.2021.102727_bib64","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nri.2016.38","article-title":"T cell responses to cytomegalovirus","volume":"16","author":"Klenerman","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2021.102727_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/v10090508","article-title":"A paradigmatic interplay between human cytomegalovirus and host immune system: possible involvement of viral antigen-driven CD8+ T cell responses in systemic sclerosis","volume":"10","author":"Arcangeletti","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.jaut.2021.102727_bib66","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1136\/annrheumdis-2019-215145","article-title":"Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis","volume":"78","author":"Becker","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102727_bib67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5301\/jsrd.5000231","article-title":"Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis","volume":"2","author":"Khanna","year":"2017","journal-title":"J. Scleroderma Relat. Disord."},{"key":"10.1016\/j.jaut.2021.102727_bib68","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-020-2113-6","article-title":"Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis","volume":"22","author":"Ledoult","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2021.102727_bib69","first-page":"1565","article-title":"Disease progression in systemic sclerosis","volume":"60","author":"Van Leeuwen","year":"2021","journal-title":"Rheumatol. (United Kingdom)."},{"key":"10.1016\/j.jaut.2021.102727_bib70","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1002\/art.34427","article-title":"Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis","volume":"64","author":"Merkel","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102727_bib71","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/art.41153","article-title":"Using autoantibodies and cutaneous subset to develop outcome-based disease classification in systemic sclerosis","volume":"72","author":"Nihtyanova","year":"2020","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102727_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21176397","article-title":"Impact of human cytomegalovirus and human herpesvirus 6 infection on the expression of factors associated with cell fibrosis and apoptosis: clues for implication in systemic sclerosis development","volume":"21","author":"Arcangeletti","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2021.102727_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051060","article-title":"Modulation of microRNome by human cytomegalovirus and human herpesvirus 6 infection in human dermal fibroblasts: possible significance in the induction of fibrosis in systemic sclerosis","volume":"10","author":"Soffritti","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jaut.2021.102727_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-015-0552-x","article-title":"Fresh insights into disease etiology and the role of microbial pathogens","volume":"18","author":"Farina","year":"2015","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jaut.2021.102727_bib75","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1128\/JCM.38.8.3135-3136.2000","article-title":"Human herpesvirus 6 infects and replicates in aortic endothelium [3]","volume":"38","author":"Rotola","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jaut.2021.102727_bib76","doi-asserted-by":"crossref","first-page":"20446","DOI":"10.1073\/pnas.0905535106","article-title":"U94 of human herpesvirus 6 inhibits in vitro angiogenesis and lymphangiogenesis","volume":"106","author":"Caruso","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2021.102727_bib77","first-page":"173","article-title":"Molecular biology and clinical associations of Roseoloviruses human herpesvirus 6 and human herpesvirus 7","volume":"30","author":"Caselli","year":"2007","journal-title":"New Microbiol."},{"key":"10.1016\/j.jaut.2021.102727_bib78","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00705-013-1902-5","article-title":"Classification of HHV-6A and HHV-6B as distinct viruses","volume":"159","author":"Ablashi","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jaut.2021.102727_bib79","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/jmv.10133","article-title":"HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines","volume":"67","author":"Caruso","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jaut.2021.102727_bib80","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/jmv.10416","article-title":"Human herpesvirus-6 modulates RANTES production in primary human endothelial cell cultures","volume":"70","author":"Caruso","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jaut.2021.102727_bib81","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-2007-956171","article-title":"Detection of herpes virus DNA in post-operative thyroid tissue specimens of patients with autoimmune thyroid disease","volume":"116","author":"Thomas","year":"2008","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.jaut.2021.102727_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002951","article-title":"Virologic and immunologic evidence supporting an association between HHV-6 and hashimoto's thyroiditis","volume":"8","author":"Caselli","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jaut.2021.102727_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.02525","article-title":"HHV-6A infection of endometrial epithelial cells induces increased endometrial NK cell-mediated cytotoxicity","volume":"8","author":"Caselli","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jaut.2021.102727_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.02143","article-title":"HHV-6A\/6B infection of NK cells modulates the expression of miRNAs and transcription factors potentially associated to impaired NK activity","volume":"8","author":"Rizzo","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jaut.2021.102727_bib85","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.coviro.2014.09.013","article-title":"Clinical impact of primary infection with roseoloviruses","volume":"9","author":"Tesini","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jaut.2021.102727_bib86","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1099\/0022-1317-72-6-1401","article-title":"Latent human herpesvirus 6 infection of human monocytes\/macrophages","volume":"72","author":"Kondo","year":"1991","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jaut.2021.102727_bib87","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/infdis\/170.1.211","article-title":"Human herpesvirus 6: a survey of presence and variant distribution in normal peripheral lymphocytes and lymphoproliferative disorders","volume":"170","author":"Di Luca","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2021.102727_bib88","doi-asserted-by":"crossref","first-page":"13911","DOI":"10.1073\/pnas.95.23.13911","article-title":"U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture","volume":"95","author":"Rotola","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2021.102727_bib89","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.virol.2005.11.018","article-title":"Human herpesvirus 6 (HHV-6) U94\/REP protein inhibits betaherpesvirus replication","volume":"346","author":"Caselli","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.jaut.2021.102727_bib90","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0896-8411(89)90174-1","article-title":"Viral genomes in lymphomas of patients with Sj\u00f6gren\u2019s Syndrome","volume":"2","author":"Fox","year":"1989","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102727_bib91","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jneuroim.2012.07.004","article-title":"Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression","volume":"251","author":"Rizzo","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2021.102727_bib92","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/jmv.23670","article-title":"Selective reactivation of human herpesvirus 6 in patients with autoimmune connective tissue diseases","volume":"85","author":"Broccolo","year":"2013","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jaut.2021.102727_bib93","series-title":"Vivo (Brooklyn)","first-page":"217","article-title":"Isolation of human herpesvirus-6 (HHV-6) from patients with collagen vascular diseases","volume":"vol. 5","author":"Krueger","year":"1991"},{"key":"10.1016\/j.jaut.2021.102727_bib94","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/clinids\/19.6.1159","article-title":"Primary sj\u00f6gren\u2019s syndrome and antibodies to human herpesvirus type 6","volume":"19","author":"Ranger-Rogez","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jaut.2021.102727_bib95","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1191\/1352458504ms1045oa","article-title":"Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the disease","volume":"10","author":"Rotola","year":"2004","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jaut.2021.102727_bib96","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/ard.2004.033514","article-title":"Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction","volume":"64","author":"\u00c1lvarez-Lafuente","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102727_bib97","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMoa074479","article-title":"HHV-6A in syncytial giant-cell hepatitis","volume":"359","author":"Potenza","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2021.102727_bib98","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2133.2009.09264.x","article-title":"Nonbacterial purpura fulminans and severe autoimmune acquired protein S deficiency associated with human herpesvirus-6 active replication","volume":"161","author":"Boccara","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102727_bib99","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jcv.2009.05.010","article-title":"Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue diseases","volume":"46","author":"Broccolo","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jaut.2021.102727_bib100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1468-1331.2009.02758.x","article-title":"MHC2TA rs4774C and HHV-6A active replication in multiple sclerosis patients","volume":"17","author":"Alvarez-Lafuente","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jaut.2021.102727_bib101","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6808061","article-title":"KIR\/HLA gene profile implication in systemic sclerosis patients from Mexico","author":"Machado-Sulbaran","year":"2019","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jaut.2021.102727_bib102","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1399-0039.2007.00844.x","article-title":"Influence of KIR gene diversity on the course of HSV-1 infection: resistance to the disease is associated with the absence of KIR2DL2 and KIR2DS2","volume":"70","author":"Estefan\u00eda","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaut.2021.102727_bib103","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.4049\/jimmunol.1103434","article-title":"Host genetic factors in susceptibility to herpes simplex type 1 virus infection: contribution of polymorphic genes at the interface of innate and adaptive immunity","volume":"188","author":"Moraru","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102727_bib104","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/jmv.23771","article-title":"High prevalence of HHV8 infection and specific killer cell immunoglobulin-like receptors allotypes in Sardinian patients with type 2 diabetes mellitus","volume":"86","author":"Caselli","year":"2014","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jaut.2021.102727_bib105","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00705-015-2490-3","article-title":"Acute human herpesvirus-6A infection of human mesothelial cells modulates HLA molecules","volume":"160","author":"Caselli","year":"2015","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jaut.2021.102727_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36146-0","article-title":"Human herpesvirus 6A and 6B inhibit in vitro angiogenesis by induction of human Leukocyte antigen G,","volume":"8","author":"Rizzo","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2021.102727_bib107","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3899\/jrheum.080552","article-title":"HLA-G expression in the skin of patients with systemic sclerosis","volume":"36","author":"Wastowski","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102727_bib108","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/cei.12633","article-title":"Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis1","volume":"181","author":"Favoino","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2021.102727_bib109","article-title":"HHV-6A infection and systemic sclerosis: clues of a possible association","volume":"8","author":"Caselli","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.jaut.2021.102727_bib110","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1128\/JCM.40.11.4131-4137.2002","article-title":"Detection of antibodies directed against human herpesvirus 6 U94\/REP in sera of patients affected by multiple sclerosis","volume":"40","author":"Caselli","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jaut.2021.102727_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01383","article-title":"The Role of endothelial progenitors in the repair of vascular damage in systemic sclerosis","volume":"9","author":"Del Papa","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2021.102727_bib112","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMra030840","article-title":"Mechanisms of disease: parvovirus B19","volume":"350","author":"Young","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2021.102727_bib113","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1073\/pnas.0602259103","article-title":"Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue","volume":"103","author":"Norja","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2021.102727_bib114","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0369-8114(02)00307-3","article-title":"Persistence of human parvovirus B19 in human tissues","volume":"50","author":"S\u00f6derlund-Venermo","year":"2002","journal-title":"Pathol. Biol."},{"key":"10.1016\/j.jaut.2021.102727_bib115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.virol.2017.08.011","article-title":"Parvovirus B19 integration into human CD36+ erythroid progenitor cells","volume":"511","author":"Janovitz","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.jaut.2021.102727_bib116","doi-asserted-by":"crossref","first-page":"9541","DOI":"10.1128\/JVI.00702-09","article-title":"The genome of human parvovirus B19 can replicate in nonpermissive cells with the help of adenovirus genes and produces infectious virus","volume":"83","author":"Guan","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2021.102727_bib117","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.virol.2010.12.019","article-title":"Transactivation of human parvovirus B19 gene expression in endothelial cells by adenoviral helper functions","volume":"411","author":"Pozzuto","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.jaut.2021.102727_bib118","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4330\/wjc.v6.i4.183","article-title":"Molecular phenotypes of human parvovirus B19 in patients with myocarditis","volume":"6","author":"Bock","year":"2014","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.jaut.2021.102727_bib119","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virusres.2014.06.017","article-title":"Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process","volume":"190","author":"Adamson-Small","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.jaut.2021.102727_bib120","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2217\/fvl-2017-0079","article-title":"How does parvovirus B19 DNA achieve lifelong persistence in human cells?","volume":"12","author":"Bua","year":"2017","journal-title":"Future Virol."},{"key":"10.1016\/j.jaut.2021.102727_bib121","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/JVI.72.4.3018-3028.1998","article-title":"Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells","volume":"72","author":"Moffatt","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2021.102727_bib122","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1128\/JVI.78.14.7775-7783.2004","article-title":"Parvovirus B19-induced apoptosis of hepatocytes","volume":"78","author":"Poole","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2021.102727_bib123","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood-2009-04-215756","article-title":"The small 11kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells","volume":"115","author":"Chen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102727_bib124","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/infdis\/jiv178","article-title":"Impaired endothelial regeneration through human parvovirus B19-infected circulating angiogenic cells in patients with cardiomyopathy","volume":"212","author":"Schmidt-Lucke","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2021.102727_bib125","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1086\/499599","article-title":"Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein","volume":"193","author":"Lu","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2021.102727_bib126","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/jclinpath-2015-203455","article-title":"The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease","volume":"69","author":"Kerr","year":"2016","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jaut.2021.102727_bib127","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<936::AID-IMMU936>3.0.CO;2-X","article-title":"Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties","volume":"28","author":"Lunardi","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2021.102727_bib128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/092986606775101715","article-title":"Autoantibody reaction to myelin basic protein by plasma parvovirus B19 IgG in MS patients","volume":"13","author":"Thomas","year":"2005","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.jaut.2021.102727_bib129","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/exmp.1999.2243","article-title":"Apoptotic cells as immunogen and antigen in the antiphospholipid syndrome","volume":"66","author":"Levine","year":"1999","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.jaut.2021.102727_bib130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067179","article-title":"Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells","volume":"8","author":"Thammasri","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2021.102727_bib131","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/JVI.76.4.2014-2018.2002","article-title":"The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity","volume":"76","author":"Dorsch","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2021.102727_bib132","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/art.11038","article-title":"Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection","volume":"48","author":"Von Landenberg","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102727_bib133","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S1568-9972(03)00014-4","article-title":"Parvovirus B19 infection and autoimmune disease","volume":"2","author":"Lehmann","year":"2003","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102727_bib134","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cca.2006.10.016","article-title":"The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production","volume":"378","author":"Tzang","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jaut.2021.102727_bib135","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.cca.2010.04.004","article-title":"The association of anti-parvovirus B19-VP1 unique region antibodies with antiphospholipid antibodies in patients with antiphospholipid syndrome","volume":"411","author":"Chen","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jaut.2021.102727_bib136","first-page":"267","article-title":"Parvovirus B19 and systemic sclerosis [8]","volume":"17","author":"Ferri","year":"1999","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102727_bib137","first-page":"718","article-title":"Parvovirus B19 infection of bone marrow in systemic sclerosis patients","volume":"17","author":"Ferri","year":"1999","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102727_bib138","first-page":"315","article-title":"Parvovirus B19 infection in the skin and bone marrow of systemic sclerosis patients","volume":"43","author":"Ferri","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102727_bib139","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.0007-0963.2004.05930.x","article-title":"Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin","volume":"150","author":"Ohtsuka","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102727_bib140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000232945","article-title":"Human parvovirus B19 (B19V) infection in systemic sclerosis patients","volume":"52","author":"Zakrzewska","year":"2009","journal-title":"Intervirology"},{"key":"10.1016\/j.jaut.2021.102727_bib141","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/infdis\/172.5.1356","article-title":"Antibodies to the nonstructural protein of parvovirus b19 in persistently infected patients: implications for pathogenesis","volume":"172","author":"Von Poblotzki","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2021.102727_bib142","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/rheumatology\/39.8.903","article-title":"Antibodies to parvovirus B19 non-structural protein are associated with chronic but not acute arthritis following B19 infection","volume":"39","author":"Kerr","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2021.102727_bib143","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/art.10346","article-title":"Parvovirus B19 infection of cultured skin fibroblasts from systemic sclerosis patients: comment on the article by Ray et al [6] (multiple letters)","volume":"46","author":"Ferri","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102727_bib144","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.0303-6987.2003.0143.x","article-title":"Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma","volume":"31","author":"Magro","year":"2004","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.jaut.2021.102727_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2005.05.003","article-title":"Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures","volume":"114","author":"Zakrzewska","year":"2005","journal-title":"Virus Res."},{"key":"10.1016\/j.jaut.2021.102727_bib146","first-page":"3526","article-title":"Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis","volume":"59","author":"Arvia","year":"2020","journal-title":"Revmatologiya"},{"key":"10.1016\/j.jaut.2021.102727_bib147","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.1128\/JVI.00649-14","article-title":"Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q","volume":"88","author":"von Kietzell","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2021.102727_bib148","series-title":"Human Parvovirus B19 (B19V) Up-Regulates CXCR4 Surface Expression of Circulating Angiogenic Cells: Implications for Cardiac Ischemia in B19V Cardiomyopathy","first-page":"456","author":"Schmidt-Lucke","year":"2018"},{"key":"10.1016\/j.jaut.2021.102727_bib149","doi-asserted-by":"crossref","DOI":"10.3390\/v11030227","article-title":"Telbivudine reduces parvovirus b19-induced apoptosis in circulating angiogenic cells","volume":"11","author":"Zobel","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.jaut.2021.102727_bib150","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1002\/art.30568","article-title":"The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis","volume":"63","author":"Artlett","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102727_bib151","first-page":"5","article-title":"Expression of NLRP3 inflammasome, cytokines and vascular mediators in the skin of systemic sclerosis patients","volume":"17","author":"Mart\u00ednez-God\u00ednez","year":"2015","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.jaut.2021.102727_bib152","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.jid.2019.03.1144","article-title":"Effects of parvovirus B19 in vitro infection on monocytes from patients with systemic sclerosis: enhanced inflammatory pathways by caspase-1 activation and cytokine production","volume":"139","author":"Zakrzewska","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2021.102727_bib153","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1002\/art.20562","article-title":"Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis","volume":"50","author":"D'Alessio","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102727_bib154","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/path.2048","article-title":"Systemic sclerosis fibroblast inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor","volume":"210","author":"Serrat\u00ec","year":"2006","journal-title":"J. Pathol."},{"key":"10.1016\/j.jaut.2021.102727_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102575","article-title":"SARS-CoV-2 infection among patients with systemic autoimmune diseases","volume":"19","author":"Emmi","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102727_bib156","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1007\/s10067-020-05334-7","article-title":"COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series","volume":"39","author":"Ferri","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102727_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102539","article-title":"What is the role of rheumatologists in the era of COVID-19?","volume":"19","author":"Marotto","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"0","key":"10.1016\/j.jaut.2021.102727_bib158","first-page":"1","article-title":"Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group","volume":"0","author":"Ursini","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102727_bib159","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1016\/S2665-9913(21)00007-2","article-title":"COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study","volume":"3","author":"Ferri","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaut.2021.102727_bib160","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2021.102727_bib161","series-title":"Environ. Health Perspect","first-page":"793","article-title":"Occupational exposure to crystalline silica and autoimmune disease","author":"Parks","year":"1999"},{"key":"10.1016\/j.jaut.2021.102727_bib162","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jaut.2012.05.002","article-title":"Epidemiology of environmental exposures and human autoimmune diseases: findings from a national institute of environmental health sciences expert panel workshop","volume":"39","author":"Miller","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102727_bib163","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/19338244.2011.564231","article-title":"Pesticide-induced scleroderma and early intensive immunosuppressive treatment","volume":"67","author":"Sozeri","year":"2012","journal-title":"Arch. Environ. Occup. Health"},{"key":"10.1016\/j.jaut.2021.102727_bib164","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(88)92082-X","article-title":"Rheumatic disease, heavy-metal pigments, and the great masters","volume":"331","author":"Pedersen","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2021.102727_bib165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fimmu.2016.00097","article-title":"Silica, silicosis, and autoimmunity","volume":"7","author":"Pollard","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2021.102727_bib166","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM200003163421105","article-title":"Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases","volume":"342","author":"Janowsky","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2021.102727_bib167","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/art.1780370203","article-title":"Silicone breast implants and rheumatic disease","volume":"37","author":"S\u00e1chez\u2010Guerrero","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102727_bib168","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/art.1780390708","article-title":"Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma)","volume":"39","author":"Hochberg","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102727_bib169","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"\u201cASIA\u201d - autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102727_bib170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12026-016-8821-y","article-title":"Two hundreds cases of ASIA syndrome following silicone implants: a comparative study of 30 years and a review of current literature","volume":"65","author":"Colaris","year":"2017","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jaut.2021.102727_bib171","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1378\/chest.92.2.260","article-title":"Silica-dust-exposed mine workers with scleroderma (systemic sclerosis)","volume":"92","author":"Cowie","year":"1987","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2021.102727_bib172","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00043764-199707000-00008","article-title":"Cancer risk and mortality patterns among silicotic men in Sweden and Denmark","volume":"39","author":"Brown","year":"1997","journal-title":"J. Occup. Environ. Med."},{"key":"10.1016\/j.jaut.2021.102727_bib173","first-page":"1286","article-title":"Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma)","volume":"22","author":"Conrad","year":"1995","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102727_bib174","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ijheh.2013.11.002","article-title":"Lymphocyte activation in silica-exposed workers","volume":"217","author":"Rocha-Parise","year":"2014","journal-title":"Int. J. Hyg Environ. Health"},{"key":"10.1016\/j.jaut.2021.102727_bib175","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/08958370490270936","article-title":"Immunoglobulin and lymphocyte responses following silica exposure in New Zealand mixed mice","volume":"16","author":"Brown","year":"2004","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.jaut.2021.102727_bib176","doi-asserted-by":"crossref","DOI":"10.1007\/s12192-014-0502-y","article-title":"Silica nanoparticles induce oxidative stress and inflammation of human peripheral blood mononuclear cells","volume":"19","author":"Mendoza","year":"2014","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.jaut.2021.102727_bib177","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3762\/bjnano.6.54","article-title":"Pulmonary surfactant augments cytotoxicity of silica nanoparticles: studies on an in vitro air-blood barrier model","volume":"6","author":"Kasper","year":"2015","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.jaut.2021.102727_bib178","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.2147\/IJN.S209458","article-title":"Repeated intravenous administration of silica nanoparticles induces pulmonary inflammation and collagen accumulation via JAK2\/STAT3 and TGF-\u03b2\/Smad3 pathways in vivo","volume":"14","author":"Yu","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.jaut.2021.102727_bib179","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0432-1","article-title":"CircHECTD1 promotes the silica-induced pulmonary endothelial-mesenchymal transition via HECTD1","volume":"9","author":"Fang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jaut.2021.102727_bib180","doi-asserted-by":"crossref","DOI":"10.1186\/s12989-020-00340-8","article-title":"Silica nanomaterials induce organ injuries by Ca2+-ROS-initiated disruption of the endothelial barrier and triggering intravascular coagulation, Part","volume":"17","author":"Wang","year":"2020","journal-title":"Fibre Toxicol"},{"key":"10.1016\/j.jaut.2021.102727_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2020.110253","article-title":"Exosomal miR-125a-5p derived from silica-exposed macrophages induces fibroblast transdifferentiation","volume":"192","author":"Wang","year":"2020","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.jaut.2021.102727_bib182","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/jcp.22739","article-title":"MAP kinase mediates silica-induced fibrotic nodule formation and collagen accumulation in fibroblasts","volume":"227","author":"Li","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jaut.2021.102727_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2019.104723","article-title":"Dose-dependent cell necrosis induced by silica nanoparticles","volume":"63","author":"Reus","year":"2020","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.jaut.2021.102727_bib184","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.semarthrit.2018.06.009","article-title":"High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: possible pathogenetic role in disease phenotypes","volume":"48","author":"Ferri","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102727_bib185","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1007\/s11547-007-0213-x","article-title":"Score visivo e indici di TC quantitativa nella fibrosi polmonare: correlazioni con i dati di compromissione funzionale","volume":"112","author":"Sverzellati","year":"2007","journal-title":"Radiol. Medica"},{"key":"10.1016\/j.jaut.2021.102727_bib186","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2017.05.004","article-title":"Unfolding the pathogenesis of scleroderma through genomics and epigenomics","volume":"83","author":"Tsou","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102727_bib187","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaut.2013.01.012","article-title":"Systemic sclerosis: genetics and epigenetics","volume":"41","author":"Luo","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102727_bib188","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","article-title":"Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients","volume":"81","author":"Ferri","year":"2002","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2021.102727_bib189","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1136\/annrheumdis-2021-219884","article-title":"Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes","volume":"80","author":"Acosta-Herrera","year":"2021","journal-title":"Ann. Rheum. Dis."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121001359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121001359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:29:08Z","timestamp":1760257748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841121001359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":189,"alternative-id":["S0896841121001359"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102727","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into the knowledge of complex diseases: Environmental infectious\/toxic agents as potential etiopathogenetic factors of systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102727"}}